Globus Medical(GMED)
Search documents
Globus Medical(GMED) - 2023 Q1 - Earnings Call Transcript
2023-05-05 03:00
Globus Medical, Inc. (NYSE:GMED) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Brian Kearns - Senior Vice President of Business Development and Investor Relations Dan Scavilla - President and CEO Keith Pfeil - Senior Vice President and Chief Financial Officer Conference Call Participants Mike Miksic - Barclays Shagun Singh - RBC David Saxon - Needham & Co Sam Dane - BTIG Kyle Rose - Canaccord Vik Chopra - Wells Fargo Operator Welcome to Globus Medical’s First Quarter 2023 Earn ...
Globus Medical(GMED) - 2023 Q1 - Quarterly Report
2023-05-04 21:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 04-3744954 (State or oth ...
Globus Medical(GMED) - 2022 Q4 - Earnings Call Transcript
2023-02-22 01:05
Globus Medical, Inc. (NYSE:GMED) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Brian Kearns - Senior Vice President of Business Development and Investor Relations Dan Scavilla - President and CEO Keith Pfeil - Senior Vice President and Chief Financial Officer Conference Call Participants Shagun Singh - RBC Capital Markets Matt Taylor - Jefferies Matt Miksic - Barclays Vik Chopra - Wells Fargo David Saxon - Needham and Company Steve Lichtman - Oppenheimer Matthew O'Brien ...
Globus Medical(GMED) - 2022 Q4 - Annual Report
2023-02-21 22:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 04-3744954 (State or other ju ...
Globus Medical(GMED) - 2022 Q2 - Earnings Call Transcript
2022-08-05 00:56
Globus Medical, Inc. (NYSE:GMED) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development & IR Daniel Scavilla - President, CEO & Director Keith Pfeil - SVP & CFO Conference Call Participants Shagun Chadha - RBC Capital Markets Vikramjeet Chopra - Wells Fargo Securities Richard Newitter - Truist Securities David Saxon - Needham & Company Jason Wittes - Loop Capital Markets Craig Bijou - Bank of America Merrill Lynch Andrew Ranieri - Morgan Stan ...
Globus Medical(GMED) - 2022 Q1 - Earnings Call Transcript
2022-05-10 21:57
Globus Medical, Inc. (NYSE:GMED) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Brian Kearns - Senior Vice President, Business Development & Investor Relations Dan Scavilla - President & Chief Executive Officer Keith Pfeil - Senior Vice President & Chief Financial Officer Conference Call Participants Shagun Singh - RBC Capital Markets Matthew O'Brien - Piper Sandler David Saxon - Needham and Company Kyle Rose - Canaccord Jason Wittes - Loop Capital Richard Newitter - Truist V ...
Globus Medical(GMED) - 2021 Q4 - Earnings Call Transcript
2022-02-18 03:16
Globus Medical, Inc. (NYSE:GMED) Q4 2021 Earnings Conference Call February 17, 2022 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development & IR David Demski - CEO, President & Director Keith Pfeil - SVP & CFO Daniel Scavilla - EVP, Chief Commercial Officer & President, Trauma Conference Call Participants Matthew Taylor - UBS Shagun Chadha - RBC Capital Markets Matthew O'Brien - Piper Sandler David Saxon - Needham & Company Craig Bijou - Bank of America Merrill Lynch Ryan Zimmerman - BTIG K ...
Globus Medical(GMED) - 2021 Q3 - Earnings Call Transcript
2021-11-05 01:04
Globus Medical, Inc. (NYSE:GMED) Q3 2021 Results Conference Call November 4, 2021 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Dave Demski - President and CEO Dan Scavilla - EVP and Chief Commercial Officer Keith Pfeil - SVP and CFO Conference Call Participants Matt Miksic - Credit Suisse Matt Taylor - UBS David Saxon - Needham & Company Sam Brodovsky - Truist Korinne Wolfmeyer - Piper Sandler Steven Lichtman - Oppenheimer & Company Operator Welcome to the Globus Medical’s ...
Globus Medical(GMED) - 2021 Q2 - Earnings Call Transcript
2021-08-05 01:15
Globus Medical, Inc. (NYSE:GMED) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants Kelly Huller – Senior Vice President-General Counsel Dave Demski – President and Chief Executive Officer Keith Pfeil – Senior Vice President and Chief Financial Officer Dan Scavilla – Executive Vice President and Chief Commercial Officer Conference Call Participants Shagun Singh – Wells Fargo Matt Miksic – Credit Suisse Richard Newitter – SVB Leerink Kyle Rose – Canaccord John Lee – UBS Drew Rani ...
Globus Medical(GMED) - 2021 Q1 - Earnings Call Transcript
2021-05-05 02:23
Globus Medical, Inc. (NYSE:GMED) Q1 2021 Earnings Conference Call May 4, 2021 4:30 PM ET Company Participants Brian Kearns - Senior Vice President of Business Development and Investor Relations Dave Demski - President and Chief Executive Officer Keith Pfeil - Senior Vice President and Chief Financial Officer Dan Scavilla - Executive Vice President, Chief Commercial Officer and President, Trauma Conference Call Participants Matt Miksic - Credit Suisse Kaila Krum - Truist Securities Steven Lichtman - Oppenh ...